The Role of Ghrelin, Neuropeptide Y and Leptin Peptides in Weight Gain after Deep Brain Stimulation for Parkinson’s Disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Stereotactic and Functional Neurosurgery

• Publication date

  2012-03-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000335045PMID 22398667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Change of the melanocortin system caused by bilateral subthalamic nucleus stimulation in Parkinson’s disease

  2011cited by this paper
• Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism

  2009cited by this paper
• Modulation of nutritional state in Parkinsonian patients with bilateral subthalamic nucleus stimulation

  2009cited by this paper
• Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression.

  2008cited by this paper
• Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up

  2008cited by this paper
• Percent body fat estimations in college men using field and laboratory methods: A three-compartment model approach

  2008cited by this paper
• Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra.

  2008cited by this paper
• Neuroendocrine control of food intake.

  2008cited by this paper
• Avenues of communication between the brain and tissues/organs involved in energy homeostasis.

  2007cited by this paper
• Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.

  2007cited by this paper
• Increase in body weight is a non-motor side effect of deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

  2007cited by this paper
• Non-motor Symptoms of Parkinson's Disease

  2007cited by this paper
• Ghrelin: a hormone regulating food intake and energy homeostasis

  2006cited by this paper
• Gut peptides in the regulation of food intake and energy homeostasis.

  2006cited by this paper
• Subthalamic nucleus stimulation in patients with Parkinson's disease does not increase serum ghrelin levels.

  2006cited by this paper
• Body weight in patients with Parkinson's disease

  2006cited by this paper
• Effects of subthalamic nucleus deep brain stimulation and levodopa on energy production rate and substrate oxidation in Parkinson's disease

  2005cited by this paper
• Weight and body mass index in Parkinson's disease patients after deep brain stimulation surgery.

  2005cited by this paper
• Hormonal regulation of food intake.

  2005cited by this paper
• The regulation of appetite

  2005cited by this paper
• Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table

  2004cited by this paper
• Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity.

  2004cited by this paper
• Eating and sleeping--their relationship to ghrelin and leptin.

  2004cited by this paper
• Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight

  2004cited by this paper
• Prevalence, etiology, and treatment of depression in Parkinson's disease.

  2003cited by this paper
• Body weight gain rate in patients with Parkinson's disease and deep brain stimulation

  2003cited by this paper
• Ghrelin-induced food intake is mediated via the orexin pathway.

  2003cited by this paper
• Olfactory function in Parkinsonian syndromes.

  2002cited by this paper
• Ganancia ponderal después de la cirugía funcional en la enfermedad de Parkinson

  2002cited by this paper
• [Weight gain after functional surgery for Parkinsons disease].

  2002cited by this paper
• Ghrelin enhances appetite and increases food intake in humans.

  2001cited by this paper
• A role for ghrelin in the central regulation of feeding

  2001cited by this paper
• Evidence for the Involvement of Dopamine D1 and D2 Receptors in Mediating the Decrease of Food Intake during Repeated Treatment with Amphetamine

  2001cited by this paper
• Interacting appetite-regulating pathways in the hypothalamic regulation of body weight.

  1999cited by this paper
• [Relationship between weight loss and dysphagia in patients with Parkinson's disease].

  1999cited by this paper
• Weight change and body composition in patients with Parkinson's disease.

  1995cited by this paper
• Increased prevalence of undernutrition in Parkinson's disease and its relationship to clinical disease parameters

  1993cited by this paper
• Raised resting energy expenditure in Parkinson's disease and its relationship to muscle rigidity.

  1992cited by this paper
• Low Body Weight in Parkinson's Disease

  1992cited by this paper
• Diet, body size and micronutrient status in Parkinson's disease.

  1992cited by this paper
• Methods for the assessment of human body composition: traditional and new.

  1987cited by this paper
• Stereotaxic Atlas of the Human Brainstem and Cerebellar Nuclei–A Variability Study

  1979cited by this paper
• Weight loss in patients treated long-term with levodopa. Metabolic aspects.

  1976cited by this paper

• Towards Adaptive Deep Brain Stimulation for Non‐Motor Symptoms in Parkinson's Disease?

  2025cites this paper
• Summarizing the Role of Selected Adipokines in Parkinson’s Disease: What Is Known About Leptin, Adiponectin, Resistin, Visfatin, and Progranulin in Neurodegeneration?

  2025cites this paper
• Inter-Organ Crosstalk in Neurodegenerative Disease

  2025cites this paper
• Multiomics approach discloses lipids and metabolites profiles associated to Parkinson's disease stages and applied therapies.

  2024cites this paper
• Associations between gut microbiota characteristics and non‐motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients

  2024cites this paper
• Effect of deep brain stimulation on postoperative body mass index: A systematic review and meta-analysis

  2024cites this paper
• Architecture of the subthalamic nucleus

  2024cites this paper
• 194 Responsive Neurostimulation Targeting the Centromedian Nucleus of the Thalamus Improves Seizure Control in Idiopathic Generalized Epilepsy and Select Multifocal Disease

  2024cites this paper
• Mechanisms and consequences of weight gain after deep brain stimulation of the subthalamic nucleus in patients with Parkinson’s disease

  2023cites this paper
• Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson’s Disease—Preliminary Studies

  2023cites this paper
• Weight and survival after deep brain stimulation for Parkinson's disease.

  2023cites this paper
• The interactions between adipose tissue secretions and Parkinson's disease: The role of leptin

  2022influential citation
• Sweets for my sweet: modulation of the limbic system drives salience for sweet foods after deep brain stimulation in Parkinson’s disease

  2021cites this paper
• Potential Crosstalk Between Parkinson's Disease and Energy Metabolism

  2021cites this paper
• Weight Change After Subthalamic Nucleus Deep Brain Stimulation in Patients With Isolated Dystonia

  2021cites this paper
• Effects of implantation of a deep brain stimulation device on patient weight in Parkinson's disease and essential tremor.

  2020cites this paper
• Internal States Influence the Representation and Modulation of Food Intake by Subthalamic Neurons

  2020cites this paper
• Assessments of plasma acyl-ghrelin levels in Parkinson's disease patients treated with deep brain stimulation.

  2020cites this paper
• Anti-neuroinflammatory effects of Eucommia ulmoides Oliv. In a Parkinson's mouse model through the regulation of p38/JNK-Fosl2 gene expression.

  2020cites this paper
• A multi-staged neuropeptide response to traumatic brain injury

  2020cites this paper
• Internal States Influence the Representation and Modulation of Food Intake by Subthalamic Neurons

  2020cites this paper
• Influence of Bilateral Subthalamic Nucleus Deep Brain Stimulation on the Lipid Profile in Patients With Parkinson's Disease

  2020cites this paper
• A systematic review of body mass gain after deep brain stimulation of the subthalamic nucleus in patients with Parkinson's disease

  2019cites this paper
• Height and weight changes after deep brain stimulation in patients with Parkinson disease: role of clinical subtypes

  2019cites this paper
• Critical Roles of Glutaredoxin in Brain Cells—Implications for Parkinson's Disease

  2018cites this paper
• Body composition assessment by bioelectrical impedance analysis among patients treated with L-dopa for Parkinson’s disease

  2018cites this paper
• Hormones of energy homeostasis : linking weight loss and cognition in Parkinson's disease?

  2018cites this paper
• Deep Brain Stimulation in Parkinson's Disease

  2018cites this paper
• Weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease is influenced by dyskinesias’ reduction and electrodes’ position

  2017cites this paper
• Weight in Parkinson's Disease: Phenotypical Significance.

  2017cites this paper
• Management of Autonomic Dysfunction in Parkinson's Disease

  2017cites this paper
• Predictors of Functional and Quality of Life Outcomes following Deep Brain Stimulation Surgery in Parkinson's Disease Patients: Disease, Patient, and Surgical Factors

  2017cites this paper
• Is there a role for ghrelin in central dopaminergic systems? Focus on nigrostriatal and mesocorticolimbic pathways

  2017cites this paper
• The neurological effects of ghrelin in brain diseases: Beyond metabolic functions

  2017cites this paper
• Czynniki ryzyka sercowo-naczyniowego u pacjentów z chorobą Parkinsona

  2017cites this paper
• Effets bénéfiques moteurs et non-moteurs et considérations économiques de la stimulation cérébrale profonde dans la maladie de Parkinson

  2016cites this paper
• Neuroendocrine abnormalities in Parkinson's disease

  2016cites this paper
• Association between subthalamic nucleus deep brain stimulation and weight gain: Results of a case-control study.

  2016cites this paper
• Neuropeptide Y: A stressful review.

  2016cites this paper
• Ghrelin and Neurodegenerative Disorders—a Review

  2016cites this paper
• Serum Leptin Levels and Cognition in Parkinson ’ s Disease Patients Parkinson

  2016cites this paper
• Serum Leptin Levels and Cognition in Parkinson's Disease Patients.

  2016cites this paper
• Gastroparesia y otros síntomas gastrointestinales en la enfermedad de Parkinson

  2015cites this paper
• [Gastroparesis and other gastrointestinal symptoms in Parkinson's disease].

  2015cites this paper
• Body weight and food intake in Parkinson's disease. A review of the association to non-motor symptoms.

  2015cites this paper
• Weight gain following subthalamic nucleus deep brain stimulation: A PET study

  2014cites this paper
• Effets non-moteurs, limitations et futur de la stimulation cérébrale profonde dans la maladie de Parkinson

  2014cites this paper
• Ghrelin and Parkinson’s Disease

  2014cites this paper
• Central Functions of the Ghrelin Receptor

  2014cites this paper
• Mechanisms of Body Weight Fluctuations in Parkinson’s Disease

  2014influential citation
• Circulating levels of adipokines in Parkinson's disease.

  2014cites this paper
• Delayed gastric emptying in Parkinson's disease

  2014cites this paper
• Ghrelin as a neuroprotective and palliative agent in Alzheimer's and Parkinson's disease.

  2013cites this paper
• Parkinson's disease and body mass index: too much or too little?

  2012cites this paper
• Decrease in Blood Cortisol Corresponds to Weight Gain following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease

  2012cites this paper
• Weight Change after Globus Pallidus Internus or Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease and Dystonia

  2012cites this paper